Zehra, K. Et Al. 2024. Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines.. Naunyn-Schmiedeberg's archives of pharmacology , vol.397, no.10 , 7913-7926.

Zehra, K., Banu, A., Can, E., & Hülya, C., (2024). Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines.. Naunyn-Schmiedeberg's archives of pharmacology , vol.397, no.10, 7913-7926.

Zehra, Kanli Et Al. "Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines.," Naunyn-Schmiedeberg's archives of pharmacology , vol.397, no.10, 7913-7926, 2024

Zehra, Kanli Et Al. "Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines.." Naunyn-Schmiedeberg's archives of pharmacology , vol.397, no.10, pp.7913-7926, 2024

Zehra, K. Et Al. (2024) . "Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines.." Naunyn-Schmiedeberg's archives of pharmacology , vol.397, no.10, pp.7913-7926.

@article{article, author={Kanli Zehra Et Al. }, title={Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines.}, journal={Naunyn-Schmiedeberg's archives of pharmacology}, year=2024, pages={7913-7926} }